2025 HCPCS Code G0483
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed
TAGS: structural methods drugs variations matrix performed necessarily immunoassays material alcohol enzymatic samples tandem calibration qualitative distinguish utilizing signal stable excluding identify isomers limited isotope individual identification quality interferences standards spectral recognized method internal specimen universally instrument validity control singleShort Description | Drug test def 22+ classes |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | January 01, 2016 |
HCPCS Action Effective Date | January 01, 2017 |
HCPCS Pricing Indicator Code | 21 - Price subject to national limitation amount |
HCPCS Type Of Service Code | 5 - Diagnostic laboratory |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number | 340 - Toxicology - - - |
Check Similar HCPCS Codes
- G9034 - Zanamivir, inh pwdr, brand
- G9035 - Oseltamivir phosp, brand
- G9036 - Rimantadine hcl, brand
- G9037 - Intrpro req fr rec phys/qhcp
- G9038 - Co-management services
- G9050 - Oncology work-up evaluation
- G9051 - Oncology tx decision-mgmt
- G9052 - Onc surveillance for disease
- G9053 - Onc expectant management pt
- G9054 - Onc supervision palliative
- G9055 - Onc visit unspecified nos
- G9056 - Onc prac mgmt adheres guide
- G9057 - Onc pract mgmt differs trial
- G9058 - Onc prac mgmt disagree w/gui
- G9059 - Onc prac mgmt pt opt alterna
- G9060 - Onc prac mgmt dif pt comorb
- G9061 - Onc prac cond noadd by guide
- G9062 - Onc prac guide differs nos
- G9063 - Onc dx nsclc stgi no progres
- G9064 - Onc dx nsclc stg2 no progres